OmicsDI
Toggle navigation
Browse
Submit Data
Databases
API
Help
Advanced
Search
8
Results
Show all
Save search
Copy query
Show results for
Unknown
(8)
Publication Date
Release Date
2025
(2)
2024
(1)
2023
(1)
2020
(1)
2017
(1)
2016
(1)
2013
(1)
Previous
page
1 / 1
You're on page
1
Next
page
Sort
by:
Relevance
Page size
10
Clinical Significance of Nuclear Yin-Yang Overexpression Evaluated by Immunohistochemistry in Tissue Microarrays and Digital Pathology Analysis: A Useful Prognostic Tool for Breast Cancer.
Not available
S-EPMC12469722
|
biostudies-literature
Cite
Early outcomes from the Minimally Invasive Right Colectomy Anastomosis study (MIRCAST).
Not available
S-EPMC10416692
|
biostudies-literature
Cite
Genome-wide association analyses identify new risk variants and the genetic architecture of amyotrophic lateral sclerosis.
Not available
S-EPMC5556360
|
biostudies-literature
Cite
Long-term effects of continuing adjuvant tamoxifen to 10 years versus stopping at 5 years after diagnosis of oestrogen receptor-positive breast cancer: ATLAS, a randomised trial.
Not available
S-EPMC3596060
|
biostudies-literature
Cite
Analysis of shared common genetic risk between amyotrophic lateral sclerosis and epilepsy.
Not available
S-EPMC7818383
|
biostudies-literature
Cite
Genetic correlation between amyotrophic lateral sclerosis and schizophrenia.
Not available
S-EPMC5364411
|
biostudies-literature
Cite
Global disparities in surgeons' workloads, academic engagement and rest periods: the on-calL shIft fOr geNEral SurgeonS (LIONESS) study.
Not available
S-EPMC11455666
|
biostudies-literature
Cite
Extended pharmacological thromboprophylaxis and clinically relevant venous thromboembolism after major abdominal and pelvic surgery: international, prospective, propensity score-weighted cohort study.
Not available
S-EPMC11894929
|
biostudies-literature
Cite
Previous
page
1 / 1
You're on page
1
Next
page
Sort
by:
Relevance
Page size
10
OmicsDI
is part of the ELIXIR infrastructure
OmicsDI is an Elixir interoperability service.
Learn more ›
Tweets